ATE381329T1 - Arzneizusammensetzungen enthaltend terbinafin und deren verwendung - Google Patents

Arzneizusammensetzungen enthaltend terbinafin und deren verwendung

Info

Publication number
ATE381329T1
ATE381329T1 AT02754918T AT02754918T ATE381329T1 AT E381329 T1 ATE381329 T1 AT E381329T1 AT 02754918 T AT02754918 T AT 02754918T AT 02754918 T AT02754918 T AT 02754918T AT E381329 T1 ATE381329 T1 AT E381329T1
Authority
AT
Austria
Prior art keywords
compositions containing
medicinal compositions
terbinafin
containing terbinafin
medicinal
Prior art date
Application number
AT02754918T
Other languages
English (en)
Inventor
Rainer Alles
Dieter Becker
Jean-Daniel Bonny
Stefan Hirsch
Oskar Kalb
Ernst Koelle
Friedrich Mayer
Anton Stuetz
Anthony Williams
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27256227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE381329(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0117760A external-priority patent/GB0117760D0/en
Priority claimed from GB0128993A external-priority patent/GB0128993D0/en
Priority claimed from GB0212209A external-priority patent/GB0212209D0/en
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE381329T1 publication Critical patent/ATE381329T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
AT02754918T 2001-07-20 2002-07-19 Arzneizusammensetzungen enthaltend terbinafin und deren verwendung ATE381329T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0117760A GB0117760D0 (en) 2001-07-20 2001-07-20 Organic compounds
GB0128993A GB0128993D0 (en) 2001-12-04 2001-12-04 Organic compounds
GB0212209A GB0212209D0 (en) 2002-05-27 2002-05-27 Organic compounds

Publications (1)

Publication Number Publication Date
ATE381329T1 true ATE381329T1 (de) 2008-01-15

Family

ID=27256227

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02754918T ATE381329T1 (de) 2001-07-20 2002-07-19 Arzneizusammensetzungen enthaltend terbinafin und deren verwendung

Country Status (28)

Country Link
US (2) US20040198838A1 (de)
EP (1) EP1411921B2 (de)
JP (3) JP2005503399A (de)
KR (2) KR100699958B1 (de)
CN (1) CN100358518C (de)
AR (1) AR034813A1 (de)
AT (1) ATE381329T1 (de)
AU (1) AU2002321249B2 (de)
BR (1) BR0211198A (de)
CA (1) CA2453263C (de)
CY (1) CY1107861T1 (de)
DE (1) DE60224194T3 (de)
DK (1) DK1411921T4 (de)
ES (1) ES2295381T5 (de)
HK (1) HK1067299A1 (de)
HU (1) HUP0401200A3 (de)
IL (2) IL159591A0 (de)
MX (1) MXPA04000627A (de)
MY (1) MY136136A (de)
NO (1) NO332268B1 (de)
NZ (1) NZ530648A (de)
PE (1) PE20030287A1 (de)
PL (1) PL365416A1 (de)
PT (1) PT1411921E (de)
RU (1) RU2298402C2 (de)
SI (1) SI1411921T2 (de)
TW (1) TWI302460B (de)
WO (1) WO2003022267A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
EP1519719A1 (de) * 2002-07-02 2005-04-06 Novartis AG Methoden zur behandlung von sinusitis
JP2005060310A (ja) * 2003-08-13 2005-03-10 Towa Yakuhin Kk 不快な味をマスキングする経口投与用製剤
JP2005187339A (ja) * 2003-12-24 2005-07-14 Iwaki Seiyaku Co Ltd 耐光性塩酸テルビナフィンフィルムコート錠
JP4999297B2 (ja) * 2005-08-10 2012-08-15 高田製薬株式会社 高含量塩酸テルビナフィン小型錠剤
US8815285B2 (en) * 2006-03-28 2014-08-26 Wockhardt Ltd. Extended release dosage forms of metoprolol
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
ES2572180T3 (es) * 2006-04-26 2016-05-30 Alphapharm Pty Ltd Formulaciones de liberación controlada que comprenden unidad(es) discreta(s) sin recubrimiento y una matriz de liberación prolongada
WO2007141282A2 (en) * 2006-06-07 2007-12-13 Novartis Ag Process for making multiparticulates using a roller compactor
TWI468191B (zh) * 2009-01-28 2015-01-11 Novartis Ag 有機化合物之調配物
WO2010086732A1 (en) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Stable compositions for nail and skin treatment
CN102198111A (zh) * 2011-06-17 2011-09-28 哈尔滨乐泰药业有限公司 一种抗真菌药物片剂的制备方法
WO2013043143A1 (ru) * 2011-09-21 2013-03-28 Slyusar Viktor Timopheevich Способ снижения лишнего веса
US10071058B2 (en) * 2012-03-07 2018-09-11 Santarus, Inc. Controlled-release solid dosage forms of mesalamine
EP4104822A1 (de) 2016-03-15 2022-12-21 Acer Therapeutics Inc. Wohlschmeckende zusammensetzungen mit natriumphenylbutyrat und verwendungen davon
US11504687B2 (en) 2016-10-11 2022-11-22 Khalifa University of Science and Technology Coated chloride salt particles and methods of making and using the same
CN109833301A (zh) * 2017-11-29 2019-06-04 天津市保灵动物保健品有限公司 一种犬猫用盐酸特比萘芬风味片及其制备工艺
CN109925296B (zh) * 2017-12-19 2021-09-07 四川济生堂药业有限公司 一种中药微丸的包衣方法
CN112156078A (zh) * 2020-11-11 2021-01-01 乐泰药业有限公司 一种盐酸特比萘芬片、其制备方法以及杂质与质量检测方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) † 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5578304A (en) * 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5415872A (en) * 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5332727A (en) * 1993-04-29 1994-07-26 Birkmayer U.S.A. Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
AU1313695A (en) * 1993-12-14 1995-07-03 Sandoz Ltd. Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates
GB2290965A (en) * 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US5814230A (en) * 1996-08-30 1998-09-29 Willis; H. Craig Apparatus and method for separation of solids from liquid
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
AU715867B2 (en) * 1997-01-06 2000-02-10 Pfizer Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
US6342250B1 (en) * 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
FR2771291B1 (fr) † 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
DE19842753A1 (de) † 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
EP2260836B1 (de) * 1998-11-25 2016-08-10 Cima Labs Inc. Schnellfreisetzende Tablette mit beschichtetem, wirkstoffhaltigem Kern und umgebender Schicht als Geschmacksbarriere
NZ513037A (en) † 1999-01-29 2003-05-30 Disphar Internat B Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6248363B1 (en) † 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1116033C (zh) * 1999-07-08 2003-07-30 齐鲁制药厂 一种治疗阴道炎的泡腾片剂及其制法
EP1202716A1 (de) * 1999-08-17 2002-05-08 Novartis Consumer Health S.A. Schnelllösliche dosierungsform und verfahren zu deren herstellung
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
AU2001239838A1 (en) † 2000-02-24 2001-09-03 Advancis Pharmaceutical Corporation Therapeutic product, use and formulation thereof
DE10017996A1 (de) * 2000-04-11 2001-10-18 Pierre Foss Lamisil-Intervall-System
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
WO2004069157A2 (en) * 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Combinational use of long-acting and short-acting anti-histamines for ocular allergies

Also Published As

Publication number Publication date
PT1411921E (pt) 2008-03-12
HUP0401200A3 (en) 2008-03-28
EP1411921B2 (de) 2010-08-18
DK1411921T3 (da) 2008-04-21
RU2298402C2 (ru) 2007-05-10
DK1411921T4 (da) 2010-11-08
JP2008280351A (ja) 2008-11-20
BR0211198A (pt) 2004-08-10
ES2295381T5 (es) 2011-01-31
AU2002321249B2 (en) 2005-10-27
SI1411921T1 (sl) 2008-06-30
KR20060076331A (ko) 2006-07-04
WO2003022267A1 (en) 2003-03-20
CA2453263A1 (en) 2003-03-20
EP1411921A1 (de) 2004-04-28
NO332268B1 (no) 2012-08-13
EP1411921B1 (de) 2007-12-19
CN100358518C (zh) 2008-01-02
KR20040028935A (ko) 2004-04-03
SI1411921T2 (sl) 2010-12-31
CN1527706A (zh) 2004-09-08
KR100651110B1 (ko) 2006-12-21
TWI302460B (en) 2008-11-01
CY1107861T1 (el) 2013-06-19
DE60224194T3 (de) 2011-03-17
JP2005503399A (ja) 2005-02-03
DE60224194T2 (de) 2008-12-24
IL159591A (en) 2012-06-28
US20040198838A1 (en) 2004-10-07
HUP0401200A2 (hu) 2004-10-28
RU2004105263A (ru) 2005-04-20
ES2295381T3 (es) 2008-04-16
US20080286356A1 (en) 2008-11-20
CA2453263C (en) 2010-12-07
JP2012136523A (ja) 2012-07-19
NO20040254L (no) 2004-03-22
DE60224194D1 (de) 2008-01-31
KR100699958B1 (ko) 2007-03-28
IL159591A0 (en) 2004-06-01
PE20030287A1 (es) 2003-05-06
MXPA04000627A (es) 2004-04-20
NZ530648A (en) 2007-04-27
HK1067299A1 (en) 2005-04-08
AR034813A1 (es) 2004-03-17
MY136136A (en) 2008-08-29
PL365416A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
ATE381329T1 (de) Arzneizusammensetzungen enthaltend terbinafin und deren verwendung
DE60207627D1 (de) Überzug und Überzugszusammensetzung
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
ATE277910T1 (de) Urazil verbindungen und deren verwendung
DE60233192D1 (de) Hydrophobe und lipophobe zusammensetzung
DE60230868D1 (de) Criptoblockierende antikörper und deren verwendung
ATE396171T1 (de) Acylierte 6,7,8,9-tetrahydro-5h- benzocycloheptenyl-amine und deren pharmazeutische verwendung
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
DE60138768D1 (de) Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln
DE60115870D1 (de) Niedrig dosierte entecavir formulierung und deren verwendung
ATE470675T1 (de) Immunoglobulinvarianten und deren verwendungen
IL157029A0 (en) Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same
ATA13842001A (de) Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
DE50111690D1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
DE60215081D1 (de) Silikonzusammensetzung und antiadhäsive Beschichtung
DE60022828D1 (de) Kosmetikeinheit und deren Zusammensetzung
DE60216345D1 (de) Gummimischung und deren Verwendung
DE502004000891D1 (de) Organosilylfunktionalisierte partikel und deren herstellung
GB0108470D0 (en) Pharmaceutical compositions and their use
DE60302107D1 (de) Saure Öl-in-Wasser emulgierte Zusammensetzungen und deren Verwendung
DE60322926D1 (de) Photopolymerisierbare zusammensetzung und verwendung davon
DE60330255D1 (de) Thermoplastharzzusammensetzung und formkörper daraus
ATE250339T1 (de) Dormanz-brechende zusammenstezung und deren verwendung
ATE341948T1 (de) Zusammensetzung enthaltend kreatin und kreatinin
DE60125374D1 (de) Bisacrylamid enthaltende dentalmassen und deren verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1411921

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1411921

Country of ref document: EP